HBM Partners
Venture Capital Grand Cayman, Cayman Islands

Description

HBM Partners is among the global leaders in healthcare-focused investing with approximately USD 1.5 billion under management. HBM focuses on development stage, growth and buy-out financings of private companies as well as investments in public companies.

Team

The info we show is based on publicly available data and some estimations

Investment Focus

Fund size
€90M
Estimated Funds left
€38M
Total investments
20
Total exits 9
Routinely invested spaces
Biotechnology 25%
Pharmaceutical 20%
Medical 12%
Therapeutics 8%
Other
View All
Health Diagnostics 7%
Biopharma 6%
Health Care 4%
Robotics 4%
Genetics 3%
Hospital 2%
Industrial 2%
Medical Device 2%
Neuroscience 2%
34%
Initial Investment Size €
million (€)
min
463k
median
3M
max
10M
Initial investment stage
Series A 2 / 16
Late Stage 9 / 16
Target geography
United States
56%
Canada
13%
Germany
13%
Switzerland
13%
Other
View All 6%
Italy 6%

All investments 16

 
connectRN
 
Newton 
 
Xcell Biosciences
Biotech, Healthtech 
San Francisco 
LATE
Gynesonics
Healthtech 
Redwood City 
EXIT
SERIES A
Symbiomix Therapeutics
Biotech, Healthtech, Pharmaceuticals 
Newark 
 
APR Applied Pharma Research
Pharmaceuticals 
Balerna 
IPO
LATE
Allena Pharmaceuticals
Biotech, Healthtech, Pharmaceuticals 
Newton 
IPO
LATE
Curetis
Biotech, Healthtech 
Holzgerlingen 
 
Odyssey Thera
Biotech 
San Ramon 
 
Reha Technology AG
Robotics, Biotech, Healthtech 
Olten 
EXIT
LATE
Sloning BioTechnology
Robotics, Biotech 
Puchheim 
EXIT
LATE
Gemin X Pharmaceuticals
Biotech, Healthtech, Pharmaceuticals 
Montréal 
IPO
LATE
Newron Pharmaceuticals
Biotech, Healthtech 
Bresso 
LATE
AGY Therapeutics
Biotech, Healthtech 
San Francisco 
EXIT
SERIES A
Aspreva Pharmaceuticals Corp
Healthtech, Pharmaceuticals 
Victoria 
IPO
LATE
Cyclacel Pharmaceuticals
Biotech, Healthtech, Pharmaceuticals 
Berkeley Heights 
EXIT
LATE
Agensys
Biotech, Healthtech, Pharmaceuticals 
Santa Monica